Literature DB >> 31448366

An image-based deep learning framework for individualizing radiotherapy dose.

Bin Lou1, Semihcan Doken2, Tingliang Zhuang3, Danielle Wingerter2, Mishka Gidwani2, Nilesh Mistry3, Lance Ladic1, Ali Kamen1, Mohamed E Abazeed2,4.   

Abstract

Background: Radiotherapy continues to be delivered uniformly without consideration of individual tumor characteristics. To advance toward more precise treatments in radiotherapy, we queried the lung computed tomography (CT)-derived feature space to identify radiation sensitivity parameters that can predict treatment failure and hence guide the individualization of radiotherapy dose.
Methods: We used a cohort-based registry of 849 patients with cancer in the lung treated with high dose radiotherapy using stereotactic body radiotherapy. We input pre-therapy lung CT images into a multi-task deep neural network, Deep Profiler, to generate an image fingerprint that primarily predicts time to event treatment outcomes and secondarily approximates classical radiomic features. We validated our findings in an independent study population (n = 95). Deep Profiler was combined with clinical variables to derive iGray, an individualized dose that estimates treatment failure probability to be <5%. Findings: Radiation treatments in patients with high Deep Profiler scores fail at a significantly higher rate than in those with low scores. The 3-year cumulative incidences of local failure were 20.3% (95% CI: 16.0-24.9) and 5.7% (95% CI: 3.5-8.8), respectively. Deep Profiler independently predicted local failure (hazard ratio 1.65, 95% 1.02-2.66, p = 0.04). Models that included Deep Profiler and clinical variables predicted treatment failures with a concordance index of 0.72 (95% CI: 0.67-0.77), a significant improvement compared to classical radiomics or clinical variables alone (p = <0.001 and <0.001, respectively). Deep Profiler performed well in an external study population (n = 95), accurately predicting treatment failures across diverse clinical settings and CT scanner types (concordance index = 0.77 [95% CI: 0.69-0.92]). iGray had a wide dose range (21.1-277 Gy, BED), suggested dose reductions in 23.3% of patients and can be safely delivered in the majority of cases. Interpretation: Our results indicate that there are image-distinct subpopulations that have differential sensitivity to radiotherapy. The image-based deep learning framework proposed herein is the first opportunity to use medical images to individualize radiotherapy dose.

Entities:  

Keywords:  artificial intelligence; personalized medicine; precision oncology; tumor heterogeneity

Year:  2019        PMID: 31448366      PMCID: PMC6708276          DOI: 10.1016/S2589-7500(19)30058-5

Source DB:  PubMed          Journal:  Lancet Digit Health        ISSN: 2589-7500


  33 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Regression modeling of competing risk using R: an in depth guide for clinicians.

Authors:  L Scrucca; A Santucci; F Aversa
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

3.  A new framework to enhance the interpretation of external validation studies of clinical prediction models.

Authors:  Thomas P A Debray; Yvonne Vergouwe; Hendrik Koffijberg; Daan Nieboer; Ewout W Steyerberg; Karel G M Moons
Journal:  J Clin Epidemiol       Date:  2014-08-30       Impact factor: 6.437

4.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

5.  Toward clinically relevant standardization of image quality.

Authors:  Ehsan Samei; Alan Rowberg; Ellie Avraham; Craig Cornelius
Journal:  J Digit Imaging       Date:  2004-12       Impact factor: 4.056

Review 6.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

7.  The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.

Authors:  Zishan Allibhai; Mojgan Taremi; Andrea Bezjak; Anthony Brade; Andrew J Hope; Alexander Sun; B C John Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-24       Impact factor: 7.038

8.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.

Authors:  David J Brenner
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

9.  DataSHIELD: an ethically robust solution to multiple-site individual-level data analysis.

Authors:  Isabelle Budin-Ljøsne; Paul Burton; Julia Isaeva; Amadou Gaye; Andrew Turner; Madeleine J Murtagh; Susan Wallace; Vincent Ferretti; Jennifer R Harris
Journal:  Public Health Genomics       Date:  2014-12-13       Impact factor: 2.000

10.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  35 in total

Review 1.  Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics.

Authors:  Mayar Allam; Shuangyi Cai; Ahmet F Coskun
Journal:  NPJ Precis Oncol       Date:  2020-05-01

Review 2.  Artificial intelligence in radiation oncology.

Authors:  Elizabeth Huynh; Ahmed Hosny; Christian Guthier; Danielle S Bitterman; Steven F Petit; Daphne A Haas-Kogan; Benjamin Kann; Hugo J W L Aerts; Raymond H Mak
Journal:  Nat Rev Clin Oncol       Date:  2020-08-25       Impact factor: 66.675

Review 3.  Artificial intelligence in diagnostic imaging: impact on the radiography profession.

Authors:  Maryann Hardy; Hugh Harvey
Journal:  Br J Radiol       Date:  2019-12-16       Impact factor: 3.039

Review 4.  Artificial Intelligence: Review of Current and Future Applications in Medicine.

Authors:  L Brannon Thomas; Stephen M Mastorides; Narayan A Viswanadhan; Colleen E Jakey; Andrew A Borkowski
Journal:  Fed Pract       Date:  2021-11

5.  Assessing the Trustworthiness of Saliency Maps for Localizing Abnormalities in Medical Imaging.

Authors:  Nishanth Arun; Nathan Gaw; Praveer Singh; Ken Chang; Mehak Aggarwal; Bryan Chen; Katharina Hoebel; Sharut Gupta; Jay Patel; Mishka Gidwani; Julius Adebayo; Matthew D Li; Jayashree Kalpathy-Cramer
Journal:  Radiol Artif Intell       Date:  2021-10-06

Review 6.  Overview of radiomics in prostate imaging and future directions.

Authors:  Hwan-Ho Cho; Chan Kyo Kim; Hyunjin Park
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

7.  Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC.

Authors:  Jacob G Scott; Geoff Sedor; Jessica A Scarborough; Michael W Kattan; Jeffrey Peacock; G Daniel Grass; Eric A Mellon; Ram Thapa; Michael Schell; Anthony Waller; Sean Poppen; George Andl; Jamie K Teer; Steven A Eschrich; Thomas J Dilling; William S Dalton; Louis B Harrison; Tim Fox; Javier F Torres-Roca
Journal:  J Thorac Oncol       Date:  2020-12-08       Impact factor: 15.609

Review 8.  The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up.

Authors:  Radouane El Ayachy; Nicolas Giraud; Paul Giraud; Catherine Durdux; Philippe Giraud; Anita Burgun; Jean Emmanuel Bibault
Journal:  Front Oncol       Date:  2021-05-05       Impact factor: 6.244

Review 9.  Medical imaging and nuclear medicine: a Lancet Oncology Commission.

Authors:  Hedvig Hricak; May Abdel-Wahab; Rifat Atun; Miriam Mikhail Lette; Diana Paez; James A Brink; Lluís Donoso-Bach; Guy Frija; Monika Hierath; Ola Holmberg; Pek-Lan Khong; Jason S Lewis; Geraldine McGinty; Wim J G Oyen; Lawrence N Shulman; Zachary J Ward; Andrew M Scott
Journal:  Lancet Oncol       Date:  2021-03-04       Impact factor: 41.316

10.  Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images.

Authors:  Runsheng Chang; Shouliang Qi; Yong Yue; Xiaoye Zhang; Jiangdian Song; Wei Qian
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.